Ελένη Κούστα

Συνεργάτες

koustaΤόπος και ημερομηνία γεννήσεως:   Κέρκυρα, 16/9/1963

Mέση εκπαίδευση: Γ΄ Λυκείο Κερκύρας, 1981, Βαθμός απολυτηρίου: 196/13.

Ανωτάτη εκπαίδευση: Ιατρική Σχολή Αθηνών (1981-1987). Βαθμός πτυχίου: Λίαν Καλώς.

ΕΙΔΙΚΟΤΗΤΑ

– 7/3/1988 -10/3/1990: Πανεπιστημιακή Παθολογική Κλινική του Δημοκρατείου Παν/μίου Θράκης στο Γενικό Κρατικό Νοσοκομείο Αλεξανδρούπολης.

– 24/4/1990 – 27/4/1992: Ενδοκρινολογική Κλινική  του Νοσοκομείου Παίδων Π&A Κυριακού Αθηνών.

– 1/10/1992 -30/9/1994: τμήματα Μεταβολισμού-Κλινικής Ενδοκρινολογίας και Αναπαραγωγικής Ενδοκρινολογίας του Πανεπιστημιακού Νοσοκομείου St. Mary’s του Λονδίνου – Imperial College οf Science, Technology and Medicine, London.

Τίτλος ειδικότητας στην Ενδοκρινολογία: 23/3/95.

Aδεια ασκήσεως υπερηχογραφήματος σχετικό με την ειδικότητα: 29/5/1996

ΔΙΔΑΚΤΟΡΙΚΗ ΔΙΑΤΡΙΒΗ-2/4/97: Χορήγηση βιοσυνθετικής αυξητικής ορμόνης σε παιδιά με χρόνια νεφρική ανεπάρκεια τελικού σταδίου που βρίσκονται σε υποκατάσταση. Ιατρική Σχολή Αθηνών, Bαθμός: Αριστα

ΠΡΟΫΠΗΡΕΣΙΑ ΜΕΤΑ ΤΗΝ ΑΠΟΚΤΗΣΗ ΕΙΔΙKΟΤΗΤΑΣ

– Από 1/10/1994 έως 30/9/95: κλινικός ερευνητής στο τμήμα Αναπαραγωγικής Ενδοκρινολογίας του Πανεπιστημιακού Νοσοκομείου St. Mary’s -Imperial College οf Science, Technology and Medicine, London.

– Από 1/10/1995 – 31/7/2000: κλινικός ερευνητής στο τμήμα Κλινικής Ενδοκρινολογίας του Πανεπιστημιακού St. Mary’s του Λονδίνου-Imperial College οf Science, Technology and Medicine, London.

–Από 15/10/2000 εως σήμερα εργάζομαι σαν ιδιώτης Ενδοκρινολόγος στη Κέρκυρα.

ΔΗΜΟΣΙΕΥΣΕΙΣ ΣΕ ΔΙΕΘΝΗ ΠΕΡΙΟΔΙΚΑ

  1. Kousta E, Kontogeorgi A, Robinson S, Johnston D G. Long-Term Metabolic Consequences in Patients with a History of Gestational Diabetes Curr Pharm Des. 2020 Nov 5.
  2. Kousta Ε, White DW, Johnston DG, Franks S. Endocrine indices of PCOS in women with polycystic ovaries but without diagnostic features of PCOS: a study of an infertility clinic population. Open Journal of Obstetrics and Gynecology, 2020, 10, 275-283
  3. Mantzouki C, Bliatka B, Iliadou P, Margeli A, Papassotiriou I, Mastorakos G, Kousta E, Goulis DG. Serum Bisphenol A Concentrations in Men with Idiopathic Infertility. Food and Chemical Toxicology. 2019; 125:562-565.
  4. Gray R, Kousta E, McCarthy M, Godsland I, Venkatesan S, Anyaoku V, Johnston D. Ethnic variation in the activity of lipid desaturases and their relationships with cardiovascular risk factors in control women and an at-risk group with previous gestational diabetes mellitus: a cross-sectional study. Lipids Health Dis. 2013 Mar 6;12(1):25.
  5. Skarpa V, Κousta E, Anyfandakis K, Vakaki M, Dolianiti M, Fotinou A, Papathanasiou A. Epidemiological characteristics of children with autoimmune thyroid disease. Hormones 2011; 10:207-214.
  6. Leka S, Kousta E, Anyfandakis K, Dolianiti M, Vakaki M, Linos D, Chrousos GP, Papathanasiou A. Primary Pigmented Nodular Adrenocortical Disease (PPNAD): A case report in a 7-year-old girl. JPEM 2011; 24:197-202.
  7. Kousta E, Papathanasiou A, Skordis N. Sex determination and disorders of sex development according to the revised nomenclature and classification in 46,XX individuals. Hormones 2010; 9(3):218-231.
  8. Scarpa V, Κousta Ε, Τertipi Α, Vakaki M, Fotinou A, Papathanasiou Α. Treatment with thyroxine reduces thyroid volume in euthyroid children and adolescents with Hashimoto thyroiditis. Horm Res Paediatr 2010;73:61–67.
  9. Kousta E, Hadjiathanasiou CG, Tolis G, Papathanasiou A. Pleiotropic genetic syndromes associated with obesity. J Pediatr Endocrinol Metab 2009, 22: 581-592.
  10. Papathanasiou A, Kousta E, Skarpa V, Papachilleos P, Petrou V, Hadjiathanasiou C. Growth hormone deficiency due to autoimmune hypophysitis in a boy with autoimmune polyendocrinopathy type 2. Hormones 2007, 6: 247-250.
  11. Kousta Ε, Lawrence NJ, Godsland IF, Penny A, Anyaoku V, Millauer BA, Robinson S, Johnston DG and McCarthy MI. Early metabolic defects following gestational diabetes in three ethnic groups of anti-GAD antibodies negative women with normal fasting glucose. Hormones 2007, 6: 138-147.
  12. Kousta E. Premature adrenarche leads to polycystic ovary syndrome? Long-term consequences. Ann N Y Acad Sci. 2006, 1092:148-57.
  13. Kousta E, Efstathiadou Z, J. Lawrence N, Jeffs J, Godsland IF, Barrett SC, Doré CJ, Penny A, Anyaoku V, Millauer BA, Cela E, Robinson S, McCarthy MI and Johnston DG. Abnormalities of Glucose Tolerance and Cardiovascular Risk Factors following Gestational Diabetes and their Association with Ethnic Origin. Diabetologia 2006, 49:36-40.
  14. Kousta E, Konstantinidis Κ, Michalakis C, Theodoropoulos GE, Vorias M, Georgiou M, Sambalis G. Ectopic thyroid tissue in the lower neck with a coexisting normally located multinodular goiter. Hormones 2005, 4: 231-234.
  15. Kousta E, Tolis G. Franks S. Polycystic Ovary Syndrome. Revised diagnostic criteria and long-term health consequences. Hormones 2005, 4: 133-147.
  16. Cela E, Robertson C, Rush K, Kousta E, White DM, Wilson H, Lyons G, Kingsley P, McCarthy MI and Franks S. Prevalence of polycystic ovaries in women with androgenic alopecia. Eur J Endocrinol, 2003, 149:439-442.
  17. Kousta E, Lawrence NJ, Godsland IF, Penny A, Anyaoku V, Millauer BA, Cela E, Johnston DG, Robinson S, McCarthy MI. Insulin resistance and beta-cell dysfunction in normoglycaemic European women with a history of gestational diabetes. Clinical Endocrinology, 2003 59:289-297.
  18. Kousta E, Parker KH, Lawrence NJ, Penny A, Millauer BA, Anyaoku V, Mulnier H, Forster DC, MacDonald IA, Robinson S, McCarthy MI, Johnston DG.Delayed metabolic and thermogenic response to a mixed meal in normoglycemic European women with previous gestational diabetes. J Clin Endocrinol Metab 2002, 87: 3407-3412.
  19. Lawrence NJ, Kousta E, Penny A, Millauer BA, Robinson S, Johnston DG, McCarthy MI. Elevation of soluble E-selectin levels following gestational diabetes is restricted to women with persistant abnormalities of glucose regulation. Clinical Endocrinology, 2002, 56: 335-340.
  20. Kousta E, Ellard S, Allen LI, Saker PJ, Huxtable SJ, Hattersley AT, McCarthy MI. Glucokinase mutations in a phenotypically selected multiethnic group of women with a history of gestational diabetes. Diabet Med 2001 18:683-684.
  21. Kousta E, Lawrence NJ, Anyaoku V, Vincent A, Johnston DG, McCarthy MI. Prevalence and features of pancreatic islet-cell autoimmunity in women with gestational diabetes from different ethnic groups. British Journal of Obstetrics and Gynaecology 2001, 108:716-720.
  22. Cassell PG, Saker PJ, Huxtable SJ, Kousta E, Jackson AE, Hattersley AT, Frayling TM, Walker M, Kopelman PG, Ramachandran A, Snehelatha C, Hitman GA, McCarthy MI. Evidence that single nucleotide polymorphism in the uncoupling protein 3 (UCP3) gene influences fat distribution in women of European and Asian origin. Diabetologia 2000, 43(12):1558-1564
  23. Kousta E, Lawrence NJ, Penny A, Millauer BA, Robinson S, Johnston DG, McCarthy MI. Women with a history of gestational diabetes are shorter than women with normal glucose tolerance in pregnancy. Diabetic Medicine, 2000, 17(11):792-797.
  24. Kousta E, Cela E, Lawrence NJ, Penny A, Millauer BA, White DM, Wilson H, Robinson S, Johnston DG, McCarthy MI, Franks S. The prevalence of polycystic ovaries in women with a history of gestational diabetes. Clinical Endocrinology, 2000, 53: 501-507.
  25. Chrisoulidou A, Kousta E, Venkatesan S, Gray R, Bannister PA, Gallagher JJ, Lawrence N, Johnston DG. Effects of growth hormone treatement on Very-low-density Lipoprotein Apolipoprotein B100 turnover in adult hypopituitarism. Metabolism. 2000, 49(5): 563-566.
  26. Kousta E, Chrisoulidou A, Lawrence NJ, Anyaoku V, Al-Shoumer KAS, Johnston DG. The effects of growth hormone replacement therapy on overnight metabolic fuels in hypopituitary patients. Clinical Endocrinology. 2000, 52: 17-24.
  27. Kousta Ε, White DM, Cela Ε, McCarthy MI, Franks S. The prevalence of polycystic ovaries in women with infertility. Human Reproduction. 1999, 14: 2720-2723.’
  28. Chrisoulidou A, Kousta E, Venkatesan S, Gray RM, Bannister PA, Gallagher JJ, Johnston DG. Very low density lipoprotein-Apo B100 kinetics in adult hypopituitarism. Metabolism. 1999, 48(8): 1057-1062.
  29. Johnston DG, Al-Shoumer KAS, Chrisoulidou A, Kousta E, Beshyah SA, Robinson S. Long-term effects of growth hormone therapy on intermediary metabolism and insulin sensitivity in hypopituitary adults. J Endocrinol Invest. 1999, 22: 37-40.
  30. Kousta E, Lawrence NJ, Penny A, Millauer BA, Robinson S, Dornhorst A, de Swiet M, Steer PJ, Grenfell A, Mather HM, Johnston DG, McCarthy MI. Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes. Diabetes care. 1999, 22(6): 933-937.
  31. Chrisoulidou A, Kousta E, Beshyah SA, Robinson S and Johnston DG. How much, and by what mechanisms, does growth hormone replacement improve the quality of life in GH-deficient adults? In Bailliere’s Clinical Endocrinology and Metabolism. Guest Editor S.N. Shalet. 1998; 12 (2): 261-279.
  32. Kousta E, Chrisoulidou A, Lawrence NJ, Al-Shoumer AS, Parker KH, McCarthy MI and Johnston DG. The circadian rhythm of leptin is preserved in growth hormone deficient hypopituitary adults. Clinical Endocrinology 1998; 48: 685-690.
  33. Kalidas K, Dow E, Saker PJ, Wareham N, Halsall D, Jackson RS, Chan SP, Gelding S, Walker M, Kousta E, Johnston DG, O’Rahilly S, McCarthy MI. Prohormone convertase 1 in obesity, gestational diabetes and NIDDM-No evidence for a major susceptibility role. Diabetes 1998; 47: 287-289.
  34. Kousta Ε, White DW, Franks S. Modern use of clomiphene citrate in induction of ovulation. Human Reproduction Update 1997; 3(4): 359-365.
  35. Kousta Ε, White DW, Piazzi A, Loumaye E, Franks S. Successful induction of ovulation and completed pregnancy using rhLH and rhFSH in a woman with Kallman‘s syndrom. Human Reproduction 1996; 11(1): 70-71.
  36. Vargemezis V, Thodis E, Pasadakis R, Martinis G, Kousta E. Efficacy of vancomycin plus tobramycin as antiperitonitis regiment for patients on CAPD. Adv Perit Dial 1990; 6: 123-124.